期刊文献+

肾癌组织中STAT3、p-STAT3的表达及其临床意义

Expressions of STAT3 and p-STAT3 in the Renal Carcinoma
下载PDF
导出
摘要 目的探讨肾癌组织中信号转导及转录活化因子3(STAT3)、磷酸化信号转导及转录活化因子3(p-STAT3)的表达及其临床意义。方法采用免疫组化S-P法检测63例肾癌和30例癌旁正常肾脏组织中STAT3和p-STAT3的表达,并分析两者与肾癌临床病理参数的关系。结果肾癌组织中STAT3和p-STAT3的阳性率分别为80.95%、74.60%,癌旁正常肾脏组织分别为33.33%、16.67%,差异均有统计学意义(P均<0.05)。肾癌组织中STAT3和p-STAT3的表达与其淋巴结转移、分化程度、临床分期有关(P均<0.05)。肾癌组织中STAT3和p-STAT3的表达呈正相关关系(rS=0.367,P<0.05)。结论肾癌组织STAT3和p-STAT3持续高表达,提示STAT3信号通路可能参与肾癌的临床进展,且与肾癌的恶性程度密切相关,联合检测可以为肾癌的临床诊断提供更为客观的参考。 Objective To investigate the expressions and clinical significance of signal transducers and activators of transcription 3(STAT3)and phosphorylated signal transducers and activators of transcription 3(p-STAT3)in the renal carcinoma. Methods Immunohistochemistry S-P method was used to detect the expressions of STAT3 and p-STAT3 in the 63 cases of renal carcinoma and the 30 cases of paraneoplastic normal renal tissue. The relationship between STAT3 or p-STAT3 and clinicopathological features were analyzed. Results The positive rates of STAT3 and p-STAT3 were 80. 95% and 74. 60% in the renal carcinoma,and were 33. 33% and 16. 67% in the paraneo-plastic normal renal tissue(P ﹤ 0. 05). The expressions of STAT3 and p-STAT3 in the renal carcinoma were related with lymph node metastasis,differentiation degree and clinical stage(P ﹤ 0. 05). The expressions of STAT3 was positively related with p-STAT3 in the renal carcinoma(rS = 0. 367,P ﹤ 0. 05). Conclusion High expressions of STAT3 and p-STAT3 are related to the canceration and improvement of renal carcinoma.
出处 《肿瘤基础与临床》 2016年第4期308-310,共3页 journal of basic and clinical oncology
关键词 肾癌 信号转导及转录活化因子3 磷酸化信号转导及转录活化因子3 renal cell carcinoma signal transducers and activators of transcription 3 phosphorylated signaltransducers and activators of transcription 3
  • 相关文献

参考文献4

二级参考文献28

  • 1王颖,罗和生,赵亮,沈志祥,涂毅.瘦素及其受体在胃癌中的表达[J].中华实验外科杂志,2005,22(5):609-610. 被引量:16
  • 2于晓棠,陆世伦,朱世能.表皮生长因子受体与肿瘤[J].复旦学报(医学版),2005,32(4):497-500. 被引量:20
  • 3GAROFALO C,SURMACZ E.Leptin and cancer[J].J Cell Physiol,2006,207(1):12-22.
  • 4HUANG S.Regulation of metastases by signal transducer and activator of transcription 3 signaling pathway:clinical implications[J].Clin Cancer Res,2007,13(5):1362-1366.
  • 5DEO D D,RAO A P,BOSE S S,et al.Differential effects of leptin on the invasive potential of androgen-dependent and -independent prostate carcinoma cells[J/OL].J Biomed Biotechnol,2008,2008:163902[2010-04-25].http://www.hindawi.com/journals/jbb/2008/163902.html.
  • 6FAVA G,ALPINI G,RYCHLICKI C,et al.Leptin enhances cholangiocarcinoma cell growth[J].Cancer Res,2008,68(16):6752-6761.
  • 7SOMASUNDAR P,MCFADDEN D W,HILEMAN S M,et al.Leptin is a growth factor in cancer[J].J Surg Res,2004,116(2):337-349.
  • 8PAI R,LIN C,TRAN T,et al.Leptin activates STAT and ERK2 pathways and induces gastric cancer cell proliferation[J].Biochem Biophys Res Commun,2005,331(4):984-992.
  • 9YAKATA Y,NAKAYAMA T,YOSHIZAKI A,et al.Expression of p-STAT3 in human gastric carcinoma:significant correlation in tumour invasion and prognosis[J].Int J Oncol,2007,30(2):437-442.
  • 10KOSHIDA Y,SAEGUSA M,OKAYASU I.Apoptosis,cell proliferation and expression of Bcl-2 and Bax in gastric carcinomas:immunohistochemical and clinicopathological study[J].Br J Cancer,1997,75(3):367-373.

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部